Human Primary Hepatocytes Market
Human Primary Hepatocytes Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Human Primary Hepatocytes Market Size and Growth
The Human Primary Hepatocytes market is witnessing steady growth, driven by increasing demand for drug discovery and toxicology studies. The global market size is projected to reach approximately $300 million by 2025, reflecting advancements in cell-based assays and personalized medicine, amid a competitive landscape of suppliers and biopharmaceutical firms. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Inc.
◍ Merck KGaA
◍ Lonza
◍ Cell Biologics
◍ Inc.
◍ PromoCell GmbH
◍ HemaCare Corporation
◍ ZenBio
◍ Inc.
◍ STEMCELL Technologies
◍ Inc.
◍ Corning Incorporated
◍ Axol Bioscience Ltd.
◍ iXCells Biotechnologies
◍ Neuromics
◍ BioIVT
The Human Primary Hepatocytes Market is driven by companies like Thermo Fisher Scientific, Merck KGaA, and Lonza, which develop high-quality hepatocyte products for drug testing and toxicology studies. Their innovations enhance research capabilities, expanding market reach. Notable revenue includes Thermo Fisher: $38 billion; Merck KGaA: $23 billion; Lonza: $5.4 billion.
Request Sample Report
◍ ScienCell Research Laboratories
Market Segmentation
By Application
By Product
◍ Hepatocyte
◍ Bile Duct Epithelial Cells ◍ Islet Cells ◍ Life Science Research Company ◍ Research Institute ◍ Others
◍ Cytoplasmic Cells
◍ Hepatic Stellate Cells
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
